These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35130254)

  • 41. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.
    Chen YF; Jobanputra P; Barton P; Bryan S; Fry-Smith A; Harris G; Taylor RS
    Health Technol Assess; 2008 Apr; 12(11):1-278, iii. PubMed ID: 18405470
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of chemopreventive response of two cycloxygenase-2 inhibitors, etoricoxib and diclofenac in rat colon cancer using FTIR and NMR spectroscopic techniques.
    Kaur Saini M; Nath Sanyal S
    Nutr Hosp; 2010; 25(4):577-85. PubMed ID: 20694294
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program.
    Krum H; Curtis SP; Kaur A; Wang H; Smugar SS; Weir MR; Laine L; Brater DC; Cannon CP
    Eur J Heart Fail; 2009 Jun; 11(6):542-50. PubMed ID: 19380329
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [By what means does the rheumatic patient with gastrointestinal risks fare best?].
    Einecke D
    MMW Fortschr Med; 2007 Mar; 149(10):18. PubMed ID: 17408040
    [No Abstract]   [Full Text] [Related]  

  • 45. The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases.
    El Miedany Y; Youssef S; Ahmed I; El Gaafary M
    Am J Gastroenterol; 2006 Feb; 101(2):311-7. PubMed ID: 16454836
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of non-steroidal anti-inflammatory drugs with different mechanisms of action on the body temperature and cyclooxygenase pathway of the arachidonic acid cascade on the model of acute general cooling (air hypothermia) in rats.
    Shtrygol S; Tovchiga O; Kudina O; Koiro O; Yudkevich T; Gorbach T
    Ceska Slov Farm; 2022; 71(5):214-223. PubMed ID: 36443026
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis.
    Ramey DR; Watson DJ; Yu C; Bolognese JA; Curtis SP; Reicin AS
    Curr Med Res Opin; 2005 May; 21(5):715-22. PubMed ID: 15974563
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative efficacy of traditional non-selective NSAIDs and selective cyclo-oxygenase-2 inhibitors in patients with acute gout: a systematic review and meta-analysis.
    Li M; Yu C; Zeng X
    BMJ Open; 2020 Sep; 10(9):e036748. PubMed ID: 32912981
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Global gastrointestinal safety profile of etoricoxib and lumiracoxib.
    Yuan Y; Hunt RH
    Curr Pharm Des; 2007; 13(22):2237-47. PubMed ID: 17691997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Etoricoxib: a review of its use in the symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute gouty arthritis.
    Croom KF; Siddiqui MA
    Drugs; 2009 Jul; 69(11):1513-32. PubMed ID: 19634927
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pain management after elective hallux valgus surgery: a prospective randomized double-blind study comparing etoricoxib and tramadol.
    Brattwall M; Turan I; Jakobsson J
    Anesth Analg; 2010 Aug; 111(2):544-9. PubMed ID: 20584877
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of ankylosing spondylitis in the UK.
    Jansen JP; Pellissier J; Choy EH; Ostor A; Nash JT; Bacon P; Hunsche E
    Curr Med Res Opin; 2007 Dec; 23(12):3069-78. PubMed ID: 17971283
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NSAID-antihypertensive drug interactions: which outpatients are at risk for a rise in systolic blood pressure?
    Floor-Schreudering A; De Smet PA; Buurma H; Kramers C; Tromp PC; Belitser SV; Bouvy ML
    Eur J Prev Cardiol; 2015 Jan; 22(1):91-9. PubMed ID: 24042856
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study.
    van der Heijde D; Baraf HS; Ramos-Remus C; Calin A; Weaver AL; Schiff M; James M; Markind JE; Reicin AS; Melian A; Dougados M
    Arthritis Rheum; 2005 Apr; 52(4):1205-15. PubMed ID: 15818702
    [TBL] [Abstract][Full Text] [Related]  

  • 55. COX-2 selective inhibitors in the treatment of arthritis: a rheumatologist perspective.
    Hochberg MC
    Curr Top Med Chem; 2005; 5(5):443-8. PubMed ID: 15974939
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tolerance to etoricoxib in 37 patients with urticaria and angioedema induced by nonsteroidal anti-inflammatory drugs.
    Muratore L; Ventura M; Calogiuri G; Calcagnile F; Quarta E; Muratore M; Ferrannini A
    Ann Allergy Asthma Immunol; 2007 Feb; 98(2):168-71. PubMed ID: 17304885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Etoricoxib.
    Cochrane DJ; Jarvis B; Keating GM
    Drugs; 2002; 62(18):2637-51; discussion 2652-3. PubMed ID: 12466002
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of etoricoxib, a cyclooxygenase-2 selective inhibitor on aberrant crypt formation and apoptosis in 1,2 dimethyl hydrazine induced colon carcinogenesis in rat model.
    Sharma P; Kaur J; Sanyal SN
    Nutr Hosp; 2010; 25(1):39-48. PubMed ID: 20204254
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of acute Achilles tendinopathy: effect of etoricoxib on pain control and leg stiffness.
    Maquirriain J; Kokalj A
    Georgian Med News; 2013 Sep; (222):36-43. PubMed ID: 24099813
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical pharmacokinetic and pharmacodynamic profile of etoricoxib.
    Takemoto JK; Reynolds JK; Remsberg CM; Vega-Villa KR; Davies NM
    Clin Pharmacokinet; 2008; 47(11):703-20. PubMed ID: 18840026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.